Allison Transmission
ALSN NYSE Construction Machinery & Heavy Transportation Equipment Financials FY2016βFY2025
Allison Transmission's revenue fell 6.7% to $3.0 billion in fiscal 2025. Its operating margin was 29.2%, down from 30.8% a year earlier. Free cash flow was $661 million, up 0.5%. It paid out $419 million in dividends and buybacks, 63% of free cash flow. The diluted share count fell 3.4%.
What Allison Transmission does
No business description yet.
- Legal name
- ALLISON TRANSMISSION HOLDINGS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-065627
0001411207
Revenue and margins
Allison Transmission had $3.0B of revenue in fiscal 2025, down 6.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 21.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $661M in fiscal 2025, 22.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Allison Transmission returned $419M to shareholders in fiscal 2025, 63% of free cash flow. The diluted share count fell 3.4%.
Value Allison Transmission yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.4B and divides by 85.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.9x Β· peers 16.4x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Allison Transmission can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $127M | $232M | $555M | $781M | $1.5B |
| Debt incl. finance leases | $2.5B | $2.5B | $2.5B | $2.4B | $2.9B |
| Net debt / EBITDA | 2.9x | 2.4x | 1.8x | 1.5x | 1.4x |
| Debt / equity | 4.0x | 2.9x | 2.0x | 1.5x | 1.6x |
| Interest coverage | 6.5x | 6.7x | 7.0x | 8.0x | 7.3x |
| Current ratio | 1.5x | 1.8x | 2.5x | 3.0x | 4.9x |
| Quick ratio | 1.0x | 1.3x | 1.9x | 2.4x | 4.2x |
| Total assets | $4.5B | $4.7B | $5.0B | $5.3B | $6.1B |
| Total liabilities | $3.8B | $3.8B | $3.8B | $3.7B | $4.2B |
| Shareholders' equity | $634M | $874M | $1.2B | $1.7B | $1.9B |
| Net debt (β = net cash) | $2.4B | $2.3B | $2.0B | $1.6B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$6.0M
5 insiders
Of sales under plans
23%
$1.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | David S. GraziosiChair, President and CEO, Director | Sold | 26,708 | $132.98 | $3.6M | Form 4 |
| Aug 11, 2026 | Eric C. ScrogginsCLO & Asst. Secretary | Sold | 1,050 | $125.00 | $0.1M | Form 4 |
| Aug 10, 2026 | Bohley G FrederickSee Remarks | Sold | 3,961 | $122.38 | $0.5M | Form 4 |
| May 8, 2026 | Scott A MellCFO & Treasurer | Sold | 2,270 | $125.00 | $0.3M | Form 4 |
| Mar 9, 2026 | Eric C. ScrogginsCLO & Asst. Secretary | Sold | 1,313 | $114.40 | $0.2M | Form 4 |
| Feb 13, 2026 | Bohley G FrederickAllison COO,Pres.&BU Leader AT | Sold plan | 10,348 | $116.40 | $1.2M | Form 4 |
| Dec 31, 2025 | John CollSVP, Global MSS | Sold plan | 1,791 | $98.79 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 9 / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β2.3% | β1.4% | β3.7% |
| Altman Z'' | 2.14 | 2.84 | 3.33 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Allison Transmission ALSN | $8.9B | β6.7% | 29.2% | 22.0% | 20.8% | 16.9x | 6 | |
| GATX GATX | $5.9B | 9.8% | β | β | 4.0% | 16.4x | β | Compare β |
| Terex TEX | $5.9B | 5.7% | 8.8% | 5.9% | 9.0% | β | 6 | Compare β |
| Oshkosh OSK | $8.3B | β2.9% | 9.0% | 5.9% | 14.8% | 14.7x | 5 | Compare β |
| Wabtec WAB | $46.0B | 7.5% | 16.1% | 13.4% | 9.1% | 33.8x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.8B | $2.3B | $2.7B | $2.7B | $2.1B | $2.4B | $2.8B | $3.0B | $3.2B | $3.0B |
| Gross profit | $864M | $1.1B | $1.4B | $1.4B | $998M | $1.1B | $1.3B | $1.5B | $1.5B | $1.5B |
| Research and development | $88.0M | $105M | $131M | $154M | $147M | $171M | $185M | $194M | $200M | $174M |
| Operating income | $452M | $652M | $923M | $892M | $534M | $669M | $784M | $919M | $992M | $880M |
| Interest expense | $78.0M | $124M | $115M | $125M | $136M | $103M | $117M | $131M | $124M | $120M |
| Pretax income | $341M | $527M | $805M | $768M | $393M | $572M | $645M | $827M | $897M | $804M |
| Income tax | $126M | $23.0M | $166M | $164M | $94.0M | $130M | $114M | $154M | $166M | $181M |
| Net income | $215M | $504M | $639M | $604M | $299M | $442M | $531M | $673M | $731M | $623M |
| Diluted EPS | $1.27 | $3.36 | $4.78 | $4.91 | $2.62 | $4.13 | $5.53 | $7.40 | $8.31 | $7.33 |
| Diluted shares | 0.17B | 0.15B | 0.13B | 0.12B | 0.11B | 0.11B | 0.10B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $591M | $658M | $837M | $847M | $561M | $635M | $657M | $784M | $801M | $836M |
| Capital expenditure | $71.0M | $91.0M | $100M | $172M | $115M | $175M | $167M | $125M | $143M | $175M |
| Free cash flow | $520M | $567M | $737M | $675M | $446M | $460M | $490M | $659M | $658M | $661M |
| Depreciation and amortization | $176M | $170M | $164M | $167M | $148M | $150M | $155M | $154M | $121M | $124M |
| Stock-based compensation | $9.0M | $12.0M | $13.0M | $13.0M | $17.0M | $14.0M | $18.0M | $22.0M | $26.0M | $27.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $232M | $0.0M | $0.0M | $23.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $256M | $885M | $609M | $393M | $225M | $513M | $278M | $263M | $254M | $328M |
| Dividends paid | $100M | $89.0M | $80.0M | $73.0M | $78.0M | $81.0M | $80.0M | $83.0M | $87.0M | $91.0M |
| Dividends and buybacks | $356M | $974M | $689M | $466M | $303M | $594M | $358M | $346M | $341M | $419M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $205M | $199M | $231M | $192M | $310M | $127M | $232M | $555M | $781M | $1.5B |
| Total debt | $2.2B | $2.6B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.4B | $2.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $548M | $632M | $725M | $686M | $756M | $671M | $866M | $1.3B | $1.5B | $2.2B |
| Current liabilities | $342M | $417M | $426M | $417M | $373M | $459M | $480M | $501M | $506M | $460M |
| Inventory | $126M | $154M | $170M | $199M | $181M | $204M | $224M | $276M | $315M | $316M |
| Property and equipment, net | $464M | $448M | $466M | $616M | $638M | $706M | $763M | $774M | $803M | $862M |
| Total assets | $4.2B | $4.2B | $4.2B | $4.5B | $4.5B | $4.5B | $4.7B | $5.0B | $5.3B | $6.1B |
| Total liabilities | $3.1B | $3.5B | $3.6B | $3.7B | $3.7B | $3.8B | $3.8B | $3.8B | $3.7B | $4.2B |
| Shareholders' equity | $1.1B | $689M | $659M | $781M | $756M | $634M | $874M | $1.2B | $1.7B | $1.9B |
| Margins | ||||||||||
| Gross margin | 47.0% | 50.0% | 52.4% | 51.7% | 48.0% | 47.7% | 46.8% | 48.4% | 47.4% | 48.6% |
| Operating margin | 24.6% | 28.8% | 34.0% | 33.1% | 25.7% | 27.9% | 28.3% | 30.3% | 30.8% | 29.2% |
| EBITDA margin | 34.1% | 36.3% | 40.1% | 39.3% | 32.8% | 34.1% | 33.9% | 35.4% | 34.5% | 33.4% |
| Net margin | 11.7% | 22.3% | 23.6% | 22.4% | 14.4% | 18.4% | 19.2% | 22.2% | 22.7% | 20.7% |
| FCF margin | 28.3% | 25.1% | 27.2% | 25.0% | 21.4% | 19.2% | 17.7% | 21.7% | 20.4% | 22.0% |
| Returns | ||||||||||
| Return on capital | 8.9% | 20.3% | 24.3% | 23.0% | 13.3% | 17.2% | 20.8% | 23.5% | 25.0% | 20.8% |
| Return on capital employed | 11.3% | 17.0% | 24.3% | 22.7% | 13.1% | 16.5% | 19.2% | 21.1% | 21.2% | 16.8% |
| Return on equity | 19.0% | 57.0% | 94.8% | 83.9% | 38.9% | 63.6% | 70.4% | 63.9% | 50.7% | 35.4% |
| Return on assets | 5.0% | 12.0% | 15.1% | 13.9% | 6.7% | 9.9% | 11.6% | 13.9% | 14.1% | 10.9% |
| Growth | ||||||||||
| Revenue growth | β7.4% | 22.9% | 19.9% | β0.6% | β22.9% | 15.4% | 15.3% | 9.6% | 6.3% | β6.7% |
| Net income growth | 18.1% | 134.4% | 26.8% | β5.5% | β50.5% | 47.8% | 20.1% | 26.7% | 8.6% | β14.8% |
| EPS growth | 23.3% | 164.6% | 42.3% | 2.7% | β46.6% | 57.6% | 33.9% | 33.8% | 12.3% | β11.8% |
| FCF growth | β0.4% | 9.0% | 30.0% | β8.4% | β33.9% | 3.1% | 6.5% | 34.5% | β0.2% | 0.5% |
| Share count change | β4.5% | β11.2% | β10.7% | β8.2% | β7.3% | β6.1% | β10.3% | β5.2% | β3.3% | β3.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.2x | 2.9x | 2.1x | 2.2x | 3.3x | 2.9x | 2.4x | 1.8x | 1.5x | 1.4x |
| Debt / equity | 2.0x | 3.7x | 3.9x | 3.3x | 3.4x | 4.0x | 2.9x | 2.0x | 1.5x | 1.6x |
| Interest coverage | 5.8x | 5.3x | 8.0x | 7.1x | 3.9x | 6.5x | 6.7x | 7.0x | 8.0x | 7.3x |
| Current ratio | 1.6x | 1.5x | 1.7x | 1.7x | 2.0x | 1.5x | 1.8x | 2.5x | 3.0x | 4.9x |
| Quick ratio | 1.2x | 1.2x | 1.3x | 1.2x | 1.5x | 1.0x | 1.3x | 1.9x | 2.4x | 4.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 4.0% | 3.7% | 6.4% | 5.5% | 7.3% | 6.0% | 4.1% | 4.4% | 5.8% |
| Stock comp / revenue | 0.5% | 0.5% | 0.5% | 0.5% | 0.8% | 0.6% | 0.7% | 0.7% | 0.8% | 0.9% |
| Payouts / FCF | 68.5% | 171.8% | 93.5% | 69.0% | 67.9% | 129.1% | 73.1% | 52.5% | 51.8% | 63.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 9.0 | 5.0 | 6.0 | 7.0 | 8.0 | 9.0 | 7.0 | 6.0 |
| Altman Z'' | 1.0 | 0.8 | 1.3 | 1.3 | 0.9 | 0.7 | 1.3 | 2.1 | 2.8 | 3.3 |
| Accruals ratio | β8.7% | β3.7% | β4.7% | β5.6% | β5.9% | β4.3% | β2.8% | β2.3% | β1.4% | β3.7% |
Source: SEC EDGAR XBRL filings (CIK 0001411207). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.